Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy

Published:2022-10-19 Issue:6 Volume:66 Page:762-766
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Orbach Rotem¹²^ORCID,Sagi Liora¹²,Sadot Efraim²³,Tokatly Latzer Itay¹²,Shtamler Anna¹,Zisberg Tehila¹,Fattal‐Valevski Aviva¹³

Affiliation:

1. Pediatric Neurology Institute, Dana‐Dwek Children's Hospital Tel Aviv Sourasky Medical Center Tel Aviv Israel

2. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

3. Pediatric Intensive Care Unit, Dana‐Dwek Children's Hospital Tel Aviv Sourasky Medical Center Tel Aviv Israel

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27731

Reference23 articles.

1. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

2. Nusinersen for the treatment of spinal muscular atrophy

3. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

4. Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into spinal muscular atrophy from molecular biomarkers;Neural Regeneration Research;2024-06-26

2. The impact of three SMN2 gene copies on clinical characteristics and effect of disease-modifying treatment in patients with spinal muscular atrophy: a systematic literature review;Frontiers in Neurology;2024-02-29

3. Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review);Neuromuscular Diseases;2023-10-30

4. Identifying Biomarkers of Spinal Muscular Atrophy for Further Development;Journal of Neuromuscular Diseases;2023-09-08

5. Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy;Journal of Clinical Medicine;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3